BMI1 and non-small cell lung carcinoma: We previously demonstrated that B lymphoma Mo-MLV insertion region 1 (BMI1) was increased in pemetrexed resistant NSCLC cells and the inhibition of BMI1 by a small molecule inhibitor suppressed the cancer stem cell activity and increased the pemetrexed sensitivity of the pemetrexed resistant cells [13].